Mehmet Furkan Burak, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fatty Acid-Binding Proteins | 4 | 2023 | 295 | 0.740 |
Why?
|
Prediabetic State | 1 | 2024 | 529 | 0.610 |
Why?
|
Adiposity | 1 | 2024 | 1844 | 0.470 |
Why?
|
Insulin Resistance | 2 | 2024 | 3910 | 0.360 |
Why?
|
Caloric Restriction | 2 | 2021 | 290 | 0.310 |
Why?
|
Obesity | 3 | 2024 | 12802 | 0.250 |
Why?
|
Inflammation | 1 | 2024 | 10692 | 0.230 |
Why?
|
Lipolysis | 2 | 2023 | 209 | 0.230 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2024 | 188 | 0.210 |
Why?
|
Lipogenesis | 1 | 2024 | 209 | 0.200 |
Why?
|
Immunity | 2 | 2024 | 994 | 0.180 |
Why?
|
Diet, Protein-Restricted | 1 | 2019 | 71 | 0.160 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9107 | 0.160 |
Why?
|
Adipose Tissue | 2 | 2024 | 3285 | 0.160 |
Why?
|
Mice, Obese | 2 | 2015 | 420 | 0.150 |
Why?
|
Glucose | 3 | 2021 | 4354 | 0.120 |
Why?
|
Endarterectomy, Carotid | 1 | 2019 | 552 | 0.110 |
Why?
|
Vascular Surgical Procedures | 1 | 2021 | 1458 | 0.110 |
Why?
|
Overweight | 1 | 2024 | 2400 | 0.100 |
Why?
|
Carotid Stenosis | 1 | 2019 | 861 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12154 | 0.100 |
Why?
|
Adipokines | 1 | 2013 | 311 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2018 | 888 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2023 | 3513 | 0.090 |
Why?
|
Preoperative Care | 1 | 2019 | 2234 | 0.090 |
Why?
|
Androgen Antagonists | 1 | 2018 | 1418 | 0.080 |
Why?
|
Fatty Liver | 1 | 2015 | 754 | 0.080 |
Why?
|
Insulin | 3 | 2023 | 6566 | 0.080 |
Why?
|
Metabolome | 1 | 2015 | 969 | 0.080 |
Why?
|
Molecular Chaperones | 1 | 2013 | 743 | 0.080 |
Why?
|
Cytokines | 2 | 2021 | 7239 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10200 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 6015 | 0.070 |
Why?
|
Body Composition | 1 | 2015 | 2388 | 0.070 |
Why?
|
Adipocytes | 1 | 2013 | 1178 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2013 | 1894 | 0.060 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13432 | 0.060 |
Why?
|
Endothelium | 1 | 2023 | 763 | 0.050 |
Why?
|
Diet Therapy | 1 | 2021 | 151 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 21724 | 0.040 |
Why?
|
Bilophila | 1 | 2019 | 12 | 0.040 |
Why?
|
Liver | 1 | 2013 | 7427 | 0.040 |
Why?
|
Humans | 7 | 2024 | 752810 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11262 | 0.030 |
Why?
|
Lipids | 2 | 2018 | 3325 | 0.030 |
Why?
|
Energy Intake | 1 | 2021 | 2125 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1341 | 0.030 |
Why?
|
Lipoproteins | 1 | 2018 | 882 | 0.030 |
Why?
|
Feces | 1 | 2019 | 1440 | 0.030 |
Why?
|
Nutritional Status | 1 | 2019 | 1600 | 0.020 |
Why?
|
Animals | 3 | 2023 | 166825 | 0.020 |
Why?
|
Homeostasis | 1 | 2021 | 3282 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2649 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1517 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1871 | 0.020 |
Why?
|
Adult | 1 | 2024 | 217168 | 0.020 |
Why?
|
Male | 5 | 2021 | 355160 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14296 | 0.020 |
Why?
|
Testosterone | 1 | 2018 | 2447 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9235 | 0.020 |
Why?
|
Hepatocytes | 1 | 2013 | 1224 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8449 | 0.020 |
Why?
|
Exercise | 1 | 2021 | 5745 | 0.020 |
Why?
|
Prospective Studies | 2 | 2019 | 53833 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6332 | 0.010 |
Why?
|
Diet | 1 | 2021 | 7950 | 0.010 |
Why?
|
Aged | 3 | 2021 | 166705 | 0.010 |
Why?
|
Mice | 2 | 2023 | 80551 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39885 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 217250 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58347 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64288 | 0.010 |
Why?
|
Female | 2 | 2021 | 386339 | 0.010 |
Why?
|